-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
A -X- _ O
total -X- _ O
of -X- _ O
453 -X- _ O
laboratory-confirmed -X- _ O
cases -X- _ O
infected -X- _ O
with -X- _ O
avian -X- _ B-Intervention
influenza -X- _ I-Intervention
A -X- _ I-Intervention
( -X- _ I-Intervention
H7N9 -X- _ I-Intervention
) -X- _ I-Intervention
virus -X- _ I-Intervention
( -X- _ O
including -X- _ O
175 -X- _ O
deaths -X- _ O
) -X- _ O
have -X- _ O
been -X- _ O
reported -X- _ O
till -X- _ O
October -X- _ O
2,2014 -X- _ O
, -X- _ O
of -X- _ O
which -X- _ O
30.68 -X- _ O
% -X- _ O
( -X- _ O
139 -X- _ O
/ -X- _ O
453 -X- _ O
) -X- _ O
of -X- _ O
the -X- _ O
cases -X- _ O
were -X- _ O
identified -X- _ O
from -X- _ O
Zhejiang -X- _ O
Province. -X- _ O
We -X- _ O
describe -X- _ O
the -X- _ O
largest -X- _ O
reported -X- _ O
cluster -X- _ O
of -X- _ O
virologically -X- _ O
confirmed -X- _ O
H7N9 -X- _ O
cases -X- _ O
, -X- _ O
comprised -X- _ O
by -X- _ O
a -X- _ O
fatal -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
and -X- _ O
two -X- _ O
mild -X- _ O
secondary -X- _ O
cases. -X- _ O
METHODS -X- _ O
: -X- _ O
A -X- _ O
retrospective -X- _ O
investigation -X- _ O
was -X- _ O
conducted -X- _ O
in -X- _ O
January -X- _ O
of -X- _ O
2014. -X- _ O
Three -X- _ O
confirmed -X- _ O
cases -X- _ O
, -X- _ O
their -X- _ O
close -X- _ O
contacts -X- _ O
, -X- _ O
and -X- _ O
relevant -X- _ O
environments -X- _ O
samples -X- _ O
were -X- _ O
tested -X- _ O
by -X- _ O
real-time -X- _ O
reverse -X- _ O
transcriptase-polymerase -X- _ O
chain -X- _ O
reaction -X- _ O
( -X- _ O
RT-PCR -X- _ O
) -X- _ O
, -X- _ O
viral -X- _ O
culture -X- _ O
, -X- _ O
and -X- _ O
sequencing. -X- _ O
Serum -X- _ O
samples -X- _ O
were -X- _ O
tested -X- _ O
by -X- _ O
haemagglutination -X- _ O
inhibition -X- _ O
( -X- _ O
HI -X- _ O
) -X- _ O
assay. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
, -X- _ O
a -X- _ O
49-year-old -X- _ O
farmer -X- _ O
with -X- _ O
type -X- _ O
II -X- _ O
diabetes -X- _ O
, -X- _ O
who -X- _ O
lived -X- _ O
with -X- _ O
his -X- _ O
daughter -X- _ O
( -X- _ O
Case -X- _ B-Patient
2 -X- _ I-Patient
, -X- _ O
aged -X- _ O
24 -X- _ O
) -X- _ O
and -X- _ O
wife -X- _ O
( -X- _ O
Case -X- _ B-Patient
3 -X- _ I-Patient
, -X- _ O
aged -X- _ O
43 -X- _ O
) -X- _ O
and -X- _ O
his -X- _ O
son-in-law -X- _ O
( -X- _ O
H7N9 -X- _ O
negative -X- _ O
) -X- _ O
. -X- _ O
The -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
and -X- _ O
Case -X- _ B-Patient
3 -X- _ I-Patient
worked -X- _ O
daily -X- _ O
in -X- _ O
a -X- _ O
live -X- _ O
bird -X- _ O
market. -X- _ O
Onset -X- _ O
of -X- _ O
illness -X- _ O
in -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
occurred -X- _ O
in -X- _ O
January -X- _ O
13 -X- _ O
, -X- _ O
2014 -X- _ O
and -X- _ O
subsequently -X- _ O
, -X- _ O
he -X- _ O
died -X- _ B-Outcome
of -X- _ I-Outcome
multi-organ -X- _ I-Outcome
failure -X- _ I-Outcome
on -X- _ I-Outcome
January -X- _ I-Outcome
20. -X- _ I-Outcome
Case -X- _ B-Outcome
2 -X- _ I-Outcome
presented -X- _ I-Outcome
with -X- _ I-Outcome
mild -X- _ I-Outcome
symptoms -X- _ I-Outcome
on -X- _ I-Outcome
January -X- _ I-Outcome
20 -X- _ I-Outcome
following -X- _ I-Outcome
frequent -X- _ I-Outcome
unprotected -X- _ I-Outcome
bed-side -X- _ I-Outcome
care -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
Index -X- _ I-Outcome
case -X- _ I-Outcome
between -X- _ I-Outcome
January -X- _ I-Outcome
14 -X- _ I-Outcome
to -X- _ I-Outcome
19 -X- _ I-Outcome
, -X- _ O
and -X- _ O
exposed -X- _ O
to -X- _ O
live -X- _ O
bird -X- _ O
market -X- _ O
on -X- _ O
January -X- _ O
17. -X- _ O
Case -X- _ B-Outcome
3 -X- _ I-Outcome
became -X- _ I-Outcome
unwell -X- _ I-Outcome
on -X- _ I-Outcome
January -X- _ I-Outcome
23 -X- _ I-Outcome
after -X- _ I-Outcome
providing -X- _ I-Outcome
bedside -X- _ I-Outcome
care -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
Index -X- _ I-Outcome
case -X- _ I-Outcome
on -X- _ I-Outcome
January -X- _ I-Outcome
17 -X- _ I-Outcome
to -X- _ I-Outcome
18 -X- _ I-Outcome
, -X- _ O
and -X- _ O
following -X- _ O
the -X- _ O
contact -X- _ O
with -X- _ O
Case -X- _ B-Patient
2 -X- _ I-Patient
during -X- _ O
January -X- _ O
21 -X- _ O
to -X- _ O
22 -X- _ O
at -X- _ O
the -X- _ O
funeral -X- _ O
of -X- _ O
the -X- _ O
Index -X- _ B-Patient
case. -X- _ I-Patient
The -X- _ O
two -X- _ O
secondary -X- _ O
cases -X- _ O
were -X- _ O
discharged -X- _ O
on -X- _ O
February -X- _ O
2 -X- _ O
and -X- _ O
5 -X- _ O
separately -X- _ O
after -X- _ O
early -X- _ O
treatment -X- _ O
with -X- _ O
antiviral -X- _ O
medication. -X- _ O
Four -X- _ O
virus -X- _ O
strains -X- _ O
were -X- _ O
isolated -X- _ O
and -X- _ O
genome -X- _ O
analyses -X- _ O
showed -X- _ O
99.6 -X- _ O
~100 -X- _ O
% -X- _ O
genetic -X- _ O
homology -X- _ O
, -X- _ O
with -X- _ O
two -X- _ O
amino -X- _ O
mutations -X- _ O
( -X- _ O
V192I -X- _ O
in -X- _ O
NS -X- _ O
and -X- _ O
V280A -X- _ O
in -X- _ O
NP -X- _ O
) -X- _ O
. -X- _ O
42 -X- _ B-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
11 -X- _ I-Outcome
/ -X- _ I-Outcome
26 -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
environmental -X- _ I-Outcome
samples -X- _ I-Outcome
collected -X- _ I-Outcome
in -X- _ I-Outcome
January -X- _ I-Outcome
were -X- _ I-Outcome
H7N9 -X- _ I-Outcome
positive. -X- _ I-Outcome
Twenty-five -X- _ B-Outcome
close -X- _ I-Outcome
contacts -X- _ I-Outcome
remained -X- _ I-Outcome
well -X- _ I-Outcome
and -X- _ I-Outcome
were -X- _ I-Outcome
negative -X- _ I-Outcome
for -X- _ I-Outcome
H7N9 -X- _ I-Outcome
infection -X- _ I-Outcome
by -X- _ I-Outcome
RT-PCR -X- _ I-Outcome
and -X- _ I-Outcome
HI -X- _ I-Outcome
assay. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
In -X- _ O
the -X- _ O
present -X- _ O
study -X- _ O
, -X- _ O
the -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
was -X- _ O
infected -X- _ O
from -X- _ O
a -X- _ O
live -X- _ O
bird -X- _ O
market -X- _ O
while -X- _ O
the -X- _ O
two -X- _ O
secondary -X- _ O
cases -X- _ O
were -X- _ O
infected -X- _ O
by -X- _ O
the -X- _ O
Index -X- _ B-Patient
case -X- _ I-Patient
during -X- _ O
unprotected -X- _ O
exposure. -X- _ O
This -X- _ O
family -X- _ O
cluster -X- _ O
is -X- _ O
, -X- _ O
therefore -X- _ O
, -X- _ O
compatible -X- _ O
with -X- _ O
non-sustained -X- _ O
person-to-person -X- _ O
transmission -X- _ O
of -X- _ O
avian -X- _ O
influenza -X- _ O
A -X- _ O
/ -X- _ O
H7N9. -X- _ O
ELECTRONIC -X- _ O
SUPPLEMENTARY -X- _ O
MATERIAL -X- _ O
: -X- _ O
The -X- _ O
online -X- _ O
version -X- _ O
of -X- _ O
this -X- _ O
article -X- _ O
( -X- _ O
doi:10.1186 -X- _ O
/ -X- _ O
s12879-014-0698-6 -X- _ O
) -X- _ O
contains -X- _ O
supplementary -X- _ O
material -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
available -X- _ O
to -X- _ O
authorized -X- _ O
users -X- _ O
. -X- _ O

